Triterpenoids constitute an important family of diverse natural products with unique biological activities.[@cit1] Their structural complexity is generated by cyclase enzymes that convert simple acyclic isoprenoid precursors into polycyclic molecules.[@cit2],[@cit3] For example, onocerane triterpenes were shown to be biosynthesized from squalene (**1**) or its oxidized derivatives (**2**, **3**) by cyclizations initiated at both termini.[@cit4] The intermediates and products can be distinguished by their oxidation level (OL), (carbo-)cyclization level (CL), and the hydration level (HL), *i.e.* the number of incorporated water molecules. Following core assembly, functional group modifications (FGMs) or C--H-oxidations[@cit5] may occur ([Scheme 1](#sch1){ref-type="fig"}). In a bioassay-guided screening for anti-malarial compounds, Schuehly and coworkers reported the isolation of a novel triterpenoid from the bark of *Cupania cinerea*.[@cit6] Cupacinoxepin (**4**) showed moderate activity against the *Plasmodium falciparum* K1 strain (8.7 μM) and features a novel fused pentacyclic onocerane scaffold composed of three six-membered carbocycles and two oxepanes. Although data from a single crystal suitable for X-ray crystallography was obtained, the absolute configuration could not be determined.[@cit6] Previous synthetic work on the onceranes[@cit7]--[@cit10] was focused on the tetracyclic *C*~2~-symmetrical congeners onocerandiol (**5**)[@cit11]--[@cit14] and α-onocerin (**6**).[@cit15]--[@cit22] The biosynthesis of onoceranoxide (**7**)[@cit23] and α-onocerin (**6**) *via***8**[@cit24],[@cit25] was hypothesized to proceed *via* cyclization of squalene and diepoxysqualene, respectively ([Scheme 1](#sch1){ref-type="fig"}). This process was elegantly mimicked by Corey\'s double allylsilane epoxypolyene cyclization.[@cit16] However, the highly substituted oxepane in cupacinoxepin (**4**) and onoceranoxide (**7**)[@cit26],[@cit27] required a novel synthetic strategy.

![Core assembly of onocerane triterpenes with regard to the oxidation level (OL), cyclization level (CL) and the hydration level (HL). LCC and LCD = *Lycopodium clavatum* C and D respectively.](c7sc03903d-s1){#sch1}

Chemical synthesis of ditertiary ethers is a daunting task.[@cit28]--[@cit38] Unfortunately, the seemingly obvious approach to form the oxepane from two tertiary alcohols is outpaced by competing cationic pathways.[@cit13],[@cit14] Inspired by the cyclization of squalene to **7***via***9** catalyzed by *Bacillus megaterium* tetraprenyl-β-curcumene cyclase (BmeTC),[@cit23] we identified myrrhanol C (**11**)[@cit39] or epoxy dienol **12** as potential precursors for the synthesis of **10**. While the actual biosynthetic pathway is unknown, the realization of an epoxydiene tricyclization appeared more feasible in a laboratory setting. Finally, oxidation of the secondary alcohol **10** to cupacinoxepin (**4**) (*via* the intermediacy of a ketone) completes the putative biosynthesis. Only a few examples of polyene cyclizations[@cit40]--[@cit45] using tertiary alcohols as nucleophiles are known,[@cit46]--[@cit48] and to the best of our knowledge polyene tricyclizations using tertiary alcohols to form oxepanes have only been achieved enzymatically so far.[@cit23],[@cit49] In order to probe this key cyclization (**12** → **10**) in the laboratory, we selected epoxy dienol **12** as our retrosynthetic target ([Scheme 2](#sch2){ref-type="fig"}).

![Retrosynthetic analysis of **10** based on an epoxypolyene cyclization of precursor **12**.](c7sc03903d-s2){#sch2}

We envisioned the cyclization precursor **12** to be generated in a *B*-alkyl Suzuki--Miyaura coupling between an alkylborane derived from **13** and vinyl iodide **14**.[@cit50] The two fragments were traced back to the readily available starting materials (+)-sclareolide (**15**) and geranyl chloride (**16**), respectively.[@cit51]--[@cit53]

The synthesis of fragment **13**[@cit54] started with the conversion of **15** into the corresponding benzyl ether **17** using a one-pot[@cit55],[@cit56] reduction/alkylation sequence ([Scheme 3](#sch3){ref-type="fig"}). To this end, reduction of (+)-sclareolide with LiAlH~4~ in THF at 0 °C [@cit57] was followed by treatment with Rochelle salt, DMF, KOH and 2-Me-C~6~H~4~CH~2~Br to afford benzyl ether **17** in excellent yield. A \[2,3\]-Wittig-type fragmentation mediated by *n*-BuLi directly yielded fragment **13** in an acceptable yield of 44% over two steps.[@cit58],[@cit59] The subtle deviation of the ether group from the literature-known benzyl ether to its 2-Me-benzyl derivative increased the yield from 21% to 44%. A screening of different ether derivatives showed alkyl substituents with benzylic hydrogen atoms in the 2-position of the aromatic ring to give higher yields of **13**. Moreover, we observed a temperature dependence of the fragmentation yield, maximizing at --13 °C.[@cit46] The configuration of **13** was confirmed by X-ray crystallography.[@cit60]

![Synthesis of fragment **13**. Reagents and conditions: (a) LiAlH~4~ (0.7 eq.), THF, 0 °C, 40 min then 2-Me-C~6~H~4~CH~2~Br (2.1 eq.), KOH (4.0 eq.), Rochelle\'s salt (1.2 eq.), DMF, 45 °C, 27 h, quant.; (b) *n*-BuLi (4.0 eq.), THF, --78 °C, 10 min to --13 °C, 90 min, 44% (over 2 steps).](c7sc03903d-s3){#sch3}

Vinyl iodide **14** was prepared from geranyl chloride *via* nucleophilic substitution with lithiated **18**[@cit61] followed by desilylation with TBAF ([Scheme 4](#sch4){ref-type="fig"}). Negishi\'s zirconium-catalyzed carboalumination[@cit62],[@cit63] of **19** with AlMe~3~ and subsequent trapping of the vinyl aluminium intermediate with iodine afforded vinyl iodide **20**.[@cit64],[@cit65] Dihydroxylation of the dimethyl-substituted alkene with the (DHQD)~2~PHAL ligand[@cit66] (33% yield, 97% ee) proceeded with low position-selectivity which is reflected by the small amount of recovered starting material (25%). Using the Corey--Noe--Lin (CNL) ligand[@cit67] increased the position-selectivity to give the terminal diol in 36% yield (94% ee) with 49% of recovered alkene.[@cit68] Mesylation of the secondary alcohol and subsequent treatment with K~2~CO~3~ afforded epoxide **14** in 81% yield.[@cit69] With alkene **13** and vinyl iodide **14** in hand, the crucial coupling was investigated ([Scheme 5](#sch5){ref-type="fig"}). Treatment of alkene **13** (neat) with 9-BBN dimer at 85 °C for 4 h led to the expected borane, which was directly used in the *B*-alkyl Suzuki--Miyaura reaction[@cit69]--[@cit71] to afford epoxy dienol **12** in 77% yield on gram scale. The stage was then set to examine the putative biomimetic tricyclization.[@cit72] We anticipated the formation of the oxepane to be unfavorable both for entropic and enthalpic reasons.[@cit73] A variety of Brønsted and Lewis acids[@cit46] failed to give the desired product, but gratifyingly, treatment of **12** with EtAlCl~2~ at --78 °C under high dilution (CH~2~Cl~2~, 1 mM) afforded a separable mixture of target compound **10** (20%) along with another pentacyclic product **21** (12%).[@cit74]--[@cit76] Spirocyclic motifs similar to **21** have been found in several bioactive natural products.[@cit77]--[@cit80] Further conditions for the tricyclization of **9** were investigated but no product formation could be observed.[@cit46]

![Synthesis of fragment **14**. Reagents and conditions: (a) *n*-BuLi (1.2 eq.), **18** (1.2 eq.), THF, --78 °C, 2.5 h then TBAF (1.3 eq.), --78 °C to 23 °C, 24 h, 82%; (b) Cp~2~ZrCl~2~ (0.25 eq.), AlMe~3~ (3.0 eq.), H~2~O (1.0 eq.), CH~2~Cl~2~, --23 °C, 1 h then I~2~ (1.2 eq.), THF, --23 °C to 23 °C, 16 h, 72%; (c) K~2~OsO~2~(OH)~4~ (0.3 mol%), CNL-ligand (0.2 mol%), K~3~Fe(CN)~6~ (3.0 eq.), MeSO~2~NH~2~ (1.0 eq.), K~2~CO~3~ (3.0 eq.), *t*-BuOH, H~2~O, 1 °C, 53 h, 36%, 94% ee, and 49% of **20**; (d) MsCl (1.1 eq.), pyridine (15 eq.), CH~2~Cl~2~, 0 °C to 23 °C, 18 h then K~2~CO~3~ (10 eq.), MeOH, 2.5 h, 81%.](c7sc03903d-s4){#sch4}

![Synthesis of cupacinoxepin **4** and onoceranoxide **7**. Reagents and conditions: (a) **13** (1.4 eq.), 9-BBN dimer (2.8 eq.), 85 °C, 4 h then **14** (1.0 eq.), Pd(dppf)Cl~2~ (0.1 eq.), AsPh~3~ (0.4 eq.), NaOH (6.0 eq.), 1 °C, 17 h, 77%; (b) EtAlCl~2~ (3.0 eq.), CH~2~Cl~2~ (1 mM), --78 °C, 1.5 h, 20% **10**, 12% **21**; (c) 4-BrC~6~H~4~COCl (5.0 eq.), 4-DMAP (20 eq.), 50 °C, CH~2~Cl~2~, 3 d, 73%; (d) TCDI (20 eq.), 4-DMAP (20 eq.), CH~2~Cl~2~, 70 °C 13.5 h, 83%; (e) *n*-Bu~3~SnH (3.0 eq.), AIBN (cat.), toluene, 160 °C, 10 min to 120 °C, 20 min then *n*-Bu~3~SnH (3.0 eq.), AIBN (cat.), 160 °C, 10 min to 120 °C, 20 min, 93%; (f) DMP (2.0 eq.), CH~2~Cl~2~, 23 °C, 4 h then AcOOH (10 eq.), NaOAc (20 eq.), 17 h then AcOOH (10 eq.), NaOAc (20 eq.), 5 h, 66%. DMP = Dess--Martin periodinane, TCDI = 1,1′-thiocarbonyldiimidazole, AIBN = azobisisobutyronitrile.](c7sc03903d-s5){#sch5}

The structures of oxepane **10** and *p*-Br-benzoate derivative **22** were confirmed by X-ray crystallography. Despite its rather low yield, the cyclization generated four stereogenic centers and the remaining carbon skeleton in a single transformation. Additionally, the secondary alcohol in **10** might serve as a handle in future SAR studies and enable the evaluation of this class of pentacyclic onocerane triterpenoids as potential antimalarial drug leads.[@cit81],[@cit82] In addition, recent work in the field of C--H functionalization has demonstrated the sclareolide scaffold to be amenable for the selective introduction of other functional groups.[@cit83]--[@cit90] Next, the major cyclization product **10** was subjected to a one-pot Dess--Martin/Baeyer--Villiger oxidation[@cit91]--[@cit94] to afford cupacinoxepin in 66% yield (1.7% overall yield starting from **16**). The spectroscopic data, including the optical rotation, matched those reported in the literature, thereby determining the absolute configuration of (+)-cupacinoxepin.[@cit6] In addition, we were able to obtain a crystal suitable for the direct determination of the absolute configuration of **4** by X-ray crystallography. Onoceranoxide **7** was formed from **10***via* formation of the thiocarbamate and subsequent reduction with tributyltin hydride in 77% yield (2 steps) (2.0% overall yield starting from **16**).[@cit95] The spectroscopic data matched those reported in the literature.[@cit26]

In order to investigate the mechanism of the epoxypolyene cyclization in more detail and to get insight into the low selectivity for the desired *trans*--*anti*--*trans* pathway, well established density functional theory (DFT) methods were applied (mPW1PW91/6-31+G(d,p)//B3LYP/6-31+G(d)).[@cit46] Two epimeric *trans*-decalin-type structures (*S*-epimer **23** and *R*-epimer **24**, [Scheme 6](#sch6){ref-type="fig"}) were predicted, based on inherent reactivity preferences (*i.e.*, in the absence of solvent or enzyme),[@cit96] to result from epoxydiene cyclization, consistent with previous work by Corey and Shenvi on related systems.[@cit75],[@cit97] The predicted major intermediate **23** is derived from a chair--chair conformation, while **24** is derived from a chair--boat conformation.[@cit75],[@cit80]

![Carbocation rearrangements leading to **10** and **21**, modeled with H^+^ in place of Lewis acid (LA).](c7sc03903d-s6){#sch6}

For **23**, 7-membered ring formation was predicted to be preferred over other pathways by several kcal mol^--1^. For **24**, 1,2-hydride shift to form **25**/6-membered ring formation was predicted to be preferred over formation of a 7-membered ring by several kcal mol^--1^. As shown in the transition state structure for formation of **25**, the hydride shift appears to be assisted by the tertiary hydroxyl group (*via* a favorable electrostatic interaction between the partially negatively charged oxygen and the partially positively charged migrating hydrogen; related interactions have been described previously).[@cit98],[@cit99] In addition, the biosynthetic relevance of the epoxypolyene cyclization was probed by incubation of **12** with BmeTC. GC-MS analysis revealed the formation of **10** along with an elimination product.[@cit46] The absence of **21** indicates the influence of BmeTC in overriding inherent reactivity and enforcing the chair--chair conformation leading to **10**.

In conclusion, we have provided access to a new class of pentacyclic onocerane triterpenoids. Additionally, we have completed the first asymmetric synthesis of antiprotozoal agent (+)-cupacinoxepin and (+)-onoceranoxide and determined their absolute configuration. By using an epoxypolyene cascade tricyclization as the key step, we were able to rapidly assemble the fused pentacyclic structure in a single synthetic operation. The putative biosynthetic precursor was assembled from two terpene derived fragments using a *B*-alkyl Suzuki--Miyaura reaction. Our synthetic route to cupacinoxepin consists of seven steps from geranyl chloride, four of which are C--C bond formations.
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